JORIZ Trademark

Trademark Overview

On Tuesday, July 8, 2008, a trademark application was filed for JORIZ with the United States Patent and Trademark Office. The USPTO has given the JORIZ trademark a serial number of 77516936. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2013. This trademark is owned by Glaxo Group Limited. The JORIZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
joriz

General Information

Serial Number77516936
Word MarkJORIZ
Filing DateTuesday, July 8, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 11, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Tuesday, September 3, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 2, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 29, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2013EXTENSION 5 GRANTED
Friday, January 25, 2013EXTENSION 5 FILED
Friday, January 25, 2013TEAS EXTENSION RECEIVED
Wednesday, August 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 7, 2012EXTENSION 4 GRANTED
Tuesday, July 31, 2012EXTENSION 4 FILED
Tuesday, July 31, 2012TEAS EXTENSION RECEIVED
Tuesday, January 24, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2012EXTENSION 3 GRANTED
Thursday, January 19, 2012EXTENSION 3 FILED
Thursday, January 19, 2012TEAS EXTENSION RECEIVED
Tuesday, July 26, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 25, 2011EXTENSION 2 GRANTED
Wednesday, July 20, 2011EXTENSION 2 FILED
Wednesday, July 20, 2011TEAS EXTENSION RECEIVED
Saturday, January 15, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 14, 2011EXTENSION 1 GRANTED
Thursday, December 16, 2010EXTENSION 1 FILED
Friday, January 14, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 16, 2010TEAS EXTENSION RECEIVED
Tuesday, August 3, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2010PUBLISHED FOR OPPOSITION
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 6, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 6, 2010ASSIGNED TO LIE
Wednesday, May 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 23, 2010LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 23, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, October 22, 2009ASSIGNED TO LIE
Thursday, April 30, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 30, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 22, 2009REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, April 22, 2009ASSIGNED TO LIE
Thursday, March 5, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 5, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 22, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, October 22, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, October 22, 2008SUSPENSION LETTER WRITTEN
Wednesday, October 15, 2008ASSIGNED TO EXAMINER
Friday, July 11, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

joriz pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic